FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:296 January 27, 2000 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Pamela Charney. 615 pp. Philadelphia, American College of Physicians, 1999. $43. ISBN 0-943126-68-1.

Over the past 25 years, widespread acceptance of pharmacologic therapies based on mechanistic concepts and remarkable advances in technology have substantially affected the natural history of coronary artery disease. The union of these diverse approaches has resulted in a major reduction in the morbidity and overall mortality associated with coronary artery disease. The decrease in mortality among women with coronary artery disease, notwithstanding, has been less than that for men. The presumed reasons for this difference are multifactorial, and the consideration of these differences forms the basis of Coronary Artery Disease in Women: What All Physicians Need to Know.

In . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.